ESR1 and breast cancer: There are conflicting reports in the literature regarding hormone status of murine breast cancer cell lines, which may be due to the use of different methods (immunostaining, PCR, or RNA-seq), lack of expected cross-reactivity between antibodies for ER that are primarily used on human samples, or simply the absence of a standardized cutoff for positivity.